Qamzova Injection
Product Images NDC 82972-001

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Qamzova (NDC 82972-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nanjing Delova Biotech Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Carton Label (Carton Label 04)

This is detailed information about an injectable medication called "QAMZOVA" which contains meloxicam, at a concentration of 30 mg/mL. Each single-dose vial contains 1 mL of the solution to be used intravenously. The medication also includes polyethylene glycol 400 and other additives like citric acid monohydrate and sodium hydrochloride. The recommended dosage is specified in the prescribing information. It is advised to keep the vials in a cool and dark place to protect them from light. The product is manufactured in China for Delova Siatech Co. Ltd.*

FDA Label Image

Figure 2 (Clinical Study 02)

FDA Label Image

Figure 3 (Clinical Study 03)

FDA Label Image

Figure 1: Structural Formula Of Meloxicam (Structure 01)

FDA Label Image

Vial Label (Vial Label 05)

This text provides detailed information about QAMZOVA™ (meloxicam) injection, a prescription medication. It contains 30 mg/mL of meloxicam and is intended for intravenous use. Each 1 mL single-dose vial should be discarded after use. The vial should be stored at 20°C to 25°C (68°F to 77°F) with slight temperature excursions allowed. The product is manufactured by Nanjing Delova Biotech Co., Ltd. in China. Additionally, it includes recommended dosage instructions and a list of ingredients. Please refer to the prescribing information for more details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.